Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety

The treatment of chronic hepatitis B is in constant evolution. Interferon, the first agent licensed for chronic hepatitis B treatment, has been superseded by the growing popularity of nucleoside/nucleotide analogues (NA). However, resistance to these agents is a major challenge. Newer NAs, such as e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Yuk-Fai, Yuen, Man-Fung, Seto, Wai-Kay, Lai, Ching-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Current Science Inc. 2011
Materias:
Hepatitis B: Epidemiology, Natural History, Treatment, and Transplantation (Thomas Berg and Steven-Huy Han, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210946/
https://www.ncbi.nlm.nih.gov/pubmed/22131901
http://dx.doi.org/10.1007/s11901-011-0109-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210946/
https://www.ncbi.nlm.nih.gov/pubmed/22131901
http://dx.doi.org/10.1007/s11901-011-0109-z

Ejemplares similares